Boston Business Journal (blog) [1] |
Intarcia makes first acquisition in quest for novel diabetes treatment [1]
Boston Business Journal (blog) Boston biotech Intarcia Therapeutics Inc. has announced plans to acquire North Carolina-based startup Phoundry Pharmaceuticals Inc., a deal that will broaden Intarcia's development of type 2 diabetes and obesity treatments. The acquisition, the first … Intarcia acquires diabetes and obesity firm Phoundry Pharmaceuticals [2]The Pharma Letter (registration) Intarcia Acquiring Phoundry Pharmaceuticals [3]Genetic Engineering & Biotechnology News Intarcia Announces AcquisitIon of Phoundry Pharmaceuticals – Second Pipeline … [4]Virtual Press Office (press release) all 12 news articles » [5] |
More details can be found at www.diabeteshowto.com [6]